Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 billion deal

Text size Aa Aa

(Reuters) - Gene sequencing company Illumina Inc <ILMN.O> said on Thursday it plans to buy Pacific Biosciences of California Inc <PACB.O> in an all-cash deal valued at $1.2 billion.

Illumina's offer of $8 per Pacific share represents a premium of about 77 percent to Pacific's Thursday close.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Shounak Dasgupta)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.